Target intelligence / Profile preview

Prolyl endopeptidase (None)

Target
None
Molecular classification
Enzyme, Serine Protease
01

Overview

Prolyl endopeptidase (PEP) is a serine protease that specifically cleaves peptide bonds at the carboxyl side of internal proline residues in peptides up to approximately 30 amino acids in length. It is involved in the degradation of neuropeptides and peptide hormones, as well as blood pressure regulation. Altered activity has been associated with neurological disorders such as schizophrenia, mania, clinical depression, and autism spectrum disorders. It also has therapeutic potential for celiac disease by degrading proline-rich gluten peptides.

Other names
Prolyl oligopeptidasePost-proline cleaving enzymePEP
02

Mechanism of action

Hydrolyzes peptide bonds at the carboxyl side of internal proline residues in peptides

03

Biological functions

Neuropeptide degradationHormone metabolismBlood pressure regulation
04

Disease associations

Neurological disordersSchizophreniaManiaClinical depressionAutism spectrum disordersCeliac disease
05

Safety considerations

Conflicting evidence regarding activity in depression

Beyond the preview

Go deeper on Prolyl endopeptidase (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prolyl endopeptidase (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call